Logo
Whalesbook
HomeStocksNewsPremiumAbout UsContact Us

La Renon Healthcare Valuation Soars to ₹11,000 Crore in Major Investor Deal

Healthcare/Biotech

|

Published on 20th November 2025, 7:37 PM

Whalesbook Logo

Author

Akshat Lakshkar | Whalesbook News Team

Overview

An investor consortium including WhiteOak Capital Management, Siguler Guff, and Creador has acquired approximately 10% of La Renon Healthcare, valuing the Ahmedabad-based pharmaceutical company at ₹11,000 crore ($1.2 billion). The deal involves stake dilution by promoters Pankaj Singh and family, and existing investors like Peak XV Partners and A91 Partners. Creador is acquiring 7% for ₹770 crore, while WhiteOak Capital and Siguler Guff jointly purchase 3% for ₹330 crore.